CareDx Inc (CDNA):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】CareDx Inc (CDNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C3424)・商品コード:DATA904C3424
・発行会社(調査会社):GlobalData
・発行日:2018年8月
・ページ数:38
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients. It develops products for transplant monitoring including AlloSure, a next-generation sequencing test to detect donor-derived cell-free DNA after transplantation. CareDx also develop and commercialize post-transplant surveillance solutions to improve recipient outcomes. It offers novel surveillance management solutions to transform long-term patient care in transplantation. CareDx is headquartered in Brisbane, California, the US.

CareDx Inc (CDNA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CareDx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CareDx Inc, Medical Devices Deals, 2012 to YTD 2018 9
CareDx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CareDx Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
CareDx Secures USD15 Million in Venture Funding 11
Partnerships 12
CareDx Enters into Co-Development Agreement with Horizon Discovery 12
Licensing Agreements 13
CareDx Amends Licensing Agreement with Stanford University 13
Equity Offering 14
CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 14
Acquisition 15
CareDx Acquires Allenex for up to USD34.1 Million 15
Allenex to Acquire Remaining Stake in Olerup SSP, AbSorber, Olerup International and Olerup for USD2.4 Million 17
CareDx Completes Acquisition of ImmuMetrix 18
CareDx Inc – Key Competitors 19
CareDx Inc – Key Employees 20
CareDx Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 09, 2018: Caredx reports second quarter results 22
May 10, 2018: CareDx Reports First Quarter Results 24
Mar 22, 2018: CareDx Announces Fourth Quarter And FY2017 Financial Results 25
Jan 08, 2018: CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results 27
Nov 09, 2017: CareDx Reports Third Quarter 2017 Financial Results 28
Aug 10, 2017: CareDx Reports Second Quarter 2017 Financial Results 29
Jun 09, 2017: CareDx Reports First Quarter 2017 Financial Results 30
May 22, 2017: CareDx Reports Preliminary First Quarter 2017 Financial Results 31
Apr 21, 2017: CareDx Reports Fourth Quarter and Full Year 2016 Financial Results 32
Mar 15, 2017: CareDx Reports Preliminary Fourth Quarter and FY 2016 Financial Results 33
Corporate Communications 35
Jun 28, 2018: Flatiron Health CMO/CSO Joins CareDx Board of Directors 35
Apr 21, 2017: CareDx Appoints Michael Bell as Chief Financial Officer 36
Other Significant Developments 37
Jun 19, 2018: CareDx set to join Russell 2000, Russell 3000 and Russell Microcap Indexes 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
CareDx Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CareDx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CareDx Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CareDx Inc, Medical Devices Deals, 2012 to YTD 2018 9
CareDx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CareDx Secures USD15 Million in Venture Funding 11
CareDx Enters into Co-Development Agreement with Horizon Discovery 12
CareDx Amends Licensing Agreement with Stanford University 13
CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 14
CareDx Acquires Allenex for up to USD34.1 Million 15
Allenex to Acquire Remaining Stake in Olerup SSP, AbSorber, Olerup International and Olerup for USD2.4 Million 17
CareDx Completes Acquisition of ImmuMetrix 18
CareDx Inc, Key Competitors 19
CareDx Inc, Key Employees 20
CareDx Inc, Subsidiaries 21

List of Figures
CareDx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CareDx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CareDx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CareDx Inc, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[CareDx Inc (CDNA):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C3424)販売に関する免責事項を必ずご確認ください。
★調査レポート[CareDx Inc (CDNA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆